LEM-06

N/A

Report date: 2023/05/17 08:51:29
NME

Base Information

Drug NameLEM-06
Drug Alias NameLEM-06
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase NSD2 inhibitors
TargetsHistone-lysine N-methyltransferase NSD2
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKyungpook National University
China Registration ClassN/A

Develop Information

Active CompaniesKyungpook National University
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A